Takeda Pharmaceutical Co Ltd

RHUMBLINE ADVISERS TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

117,636

Value ($000)

1,834

Weight

0.0%

2020 Q3 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,834	0.0%	117,636	12/31/2025
2025 Q3	11/6/2025	881	0.0%	60,180	9/30/2025
2025 Q2	8/12/2025	1,050	0.0%	67,900	6/30/2025
2025 Q1	5/29/2025	1,050	0.0%	70,632	3/31/2025
2024 Q4	5/29/2025	987	0.0%	74,537	12/31/2024
2024 Q3	11/12/2024	1,057	0.0%	74,349	9/30/2024
2024 Q2	8/1/2024	962	0.0%	74,349	6/30/2024
2024 Q1	5/9/2024	945	0.0%	68,046	3/31/2024
2023 Q4	2/8/2024	822	0.0%	57,626	12/31/2023
2023 Q3	11/9/2023	896	0.0%	57,891	9/30/2023
2023 Q2	8/8/2023	900	0.0%	57,316	6/30/2023
2020 Q4	2/10/2021	274	0.0%	15,036	12/31/2020
2020 Q3	11/12/2020	201	0.0%	11,266	9/30/2020